Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 349

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer

Open access
Cho, Jae Yong, Lim, Jae Yun, Cheong, Jae Ho, Park, Yun-Yong, Yoon, Se-Lyun, Kim, Soo Mi, Kim, Sang-Bae, Kim, Hoguen, Hong, Soon Won, Park, Young Nyun, Noh, Sung Hoon, Park, Eun Sung, Chu, In-Sun, Hong, Waun Ki, Ajani, Jaffer A., Lee, Ju-Seog·2011·Clinical Cancer Research

Abstract

Purpose: Despite continual efforts to develop a prognostic model of gastric cancer by using clinical and pathologic parameters, a clinical test that can discriminate patients with good outcomes from those with poor outcomes after gastric cancer surgery has not been established. We aim to develop practical biomarker-based risk score that can predict relapse of gastric cancer after surgical treatment. Experimental Design: Microarray technologies were used to generate and analyze gene expression profiling data from 65 gastric cancer patients to identify biomarker genes associated with relapse. The association of expression patterns of identified genes with relapse and overall survival was validated in independent gastric cancer patients. Results: We uncovered two subgroups of gastric cancer that were strongly associated with the prognosis. For the easy translation of our findings into practice, we developed a scoring system based on the expression of six genes that predicted the likelihood of relapse after curative resection. In multivariate analysis, the risk score was an independent predictor of relapse in a cohort of 96 patients. We were able to validate the robustness of the six-gene signature in an additional independent cohort. Conclusions: The risk score derived from the six-gene set successfully prognosticated the relapse of gastric cancer patients after gastrectomy. Clin Cancer Res; 17(7); 1850–7. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-10-2180

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 349

Metadata

Authors
Cho, J. Y., Lim, J. Y., Cheong, J. H., Park, Y.-Y., Yoon, S.-L., Kim, S. M., Kim, S.-B., Kim, H., Hong, S. W., Park, Y. N., Noh, S. H., Park, E. S., Chu, I.-S., Hong, W. K., Ajani, J. A., & Lee, J.-S.
Venue
Clinical Cancer Research
Published
2011-03-31
Volume
17
Issue
7
Pages
1850-1857
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2101802836
Cited by
349
References
25
FWCI
14.10
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-10-2180
The paper
Cho, J. Y., Lim, J. Y., Cheong, J. H., Park, Y.-Y., Yoon, S.-L., Kim, S. M., Kim, S.-B., Kim, H., Hong, S. W., Park, Y. N., Noh, S. H., Park, E. S., Chu, I.-S., Hong, W. K., Ajani, J. A., & Lee, J.-S. (2011). Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-10-2180

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.